Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1997 Oct 1;504(Pt 1):103–112. doi: 10.1111/j.1469-7793.1997.103bf.x

Immunoglobulins from motoneurone disease patients enhance glutamate release from rat hippocampal neurones in culture.

P R Andjus 1, Z Stevic-Marinkovic 1, E Cherubini 1
PMCID: PMC1159940  PMID: 9350622

Abstract

1. The whole-cell configuration of the patch-clamp technique was used to study the effects of immunoglobulins (IgGs) from patients affected by amyotrophic lateral sclerosis (ALS) on spontaneous glutamatergic currents in rat hippocampal cells in culture. 2. Focal application of ALS IgGs (100 micrograms ml-1) to hippocampal cells induced a rise in frequency but not in amplitude of spontaneous excitatory postsynaptic currents (SEPSC) which outlasted the period of IgG application. The mean frequency ratio (ALS over control) was 3.2 +/- 0.6 (n = 19). No changes in frequency or amplitude of SEPSCs were observed after treatment with IgGs obtained from healthy donors (n = 5) or from patients with Alzheimer's disease (n = 4). 3. ALS IgGs also increased the frequency (by a factor of 2.0 +/- 0.3) but not the amplitude of miniature excitatory postsynaptic currents (mEPSC) recorded in the presence of TTX (n = 19). A rise in frequency of mEPSC was also seen in cells superfused with a calcium-free solution (n = 4). 4. In the presence of TTX, ALS IgGs did not modify the amplitude or the shape of currents evoked by AMPA (100 microM), recorded at a holding potential of -50 mV. 5. It is concluded that ALS IgGs enhance both SEPSCs and mEPSCs through a presynaptic type of action. The excessive release of glutamate from nerve endings may be the cause of motoneurone death in ALS patients.

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andjus P. R., Khiroug L., Nistri A., Cherubini E. ALS IgGs suppress [Ca2+]i rise through P/Q-type calcium channels in central neurones in culture. Neuroreport. 1996 Aug 12;7(12):1914–1916. doi: 10.1097/00001756-199608120-00008. [DOI] [PubMed] [Google Scholar]
  2. Appel S. H., Engelhardt J. I., García J., Stefani E. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):647–651. doi: 10.1073/pnas.88.2.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Appel S. H. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. Trends Neurosci. 1993 Jan;16(1):3–5. doi: 10.1016/0166-2236(93)90039-o. [DOI] [PubMed] [Google Scholar]
  4. Arsac C., Raymond C., Martin-Moutot N., Dargent B., Couraud F., Pouget J., Seagar M. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann Neurol. 1996 Nov;40(5):695–700. doi: 10.1002/ana.410400504. [DOI] [PubMed] [Google Scholar]
  5. Ashizawa T., Oshima M., Ruan K. H., Atassi M. Z. Autoimmune recognition profile of the alpha chain of human acetylcholine receptor in myasthenia gravis. Adv Exp Med Biol. 1991;303:255–261. doi: 10.1007/978-1-4684-6000-1_29. [DOI] [PubMed] [Google Scholar]
  6. Greengard P., Valtorta F., Czernik A. J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 1993 Feb 5;259(5096):780–785. doi: 10.1126/science.8430330. [DOI] [PubMed] [Google Scholar]
  7. Kimura F., Smith R. G., Delbono O., Nyormoi O., Schneider T., Nastainczyk W., Hofmann F., Stefani E., Appel S. H. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann Neurol. 1994 Feb;35(2):164–171. doi: 10.1002/ana.410350207. [DOI] [PubMed] [Google Scholar]
  8. Krieger C., Lanius R. A., Pelech S. L., Shaw C. A. Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C. Trends Pharmacol Sci. 1996 Mar;17(3):114–120. doi: 10.1016/0165-6147(96)10004-3. [DOI] [PubMed] [Google Scholar]
  9. Llinás R., Sugimori M., Cherksey B. D., Smith R. G., Delbono O., Stefani E., Appel S. IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11743–11747. doi: 10.1073/pnas.90.24.11743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Malgaroli A., Tsien R. W. Glutamate-induced long-term potentiation of the frequency of miniature synaptic currents in cultured hippocampal neurons. Nature. 1992 May 14;357(6374):134–139. doi: 10.1038/357134a0. [DOI] [PubMed] [Google Scholar]
  11. Mosier D. R., Baldelli P., Delbono O., Smith R. G., Alexianu M. E., Appel S. H., Stefani E. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line. Ann Neurol. 1995 Jan;37(1):102–109. doi: 10.1002/ana.410370119. [DOI] [PubMed] [Google Scholar]
  12. Nistri A., Cherubini E. Depression of a sustained calcium current by kainate in rat hippocampal neurones in vitro. J Physiol. 1991 Apr;435:465–481. doi: 10.1113/jphysiol.1991.sp018519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nyormoi O. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations. Ann Neurol. 1996 Nov;40(5):701–706. doi: 10.1002/ana.410400505. [DOI] [PubMed] [Google Scholar]
  14. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol. 1990 Jul;28(1):3–8. doi: 10.1002/ana.410280103. [DOI] [PubMed] [Google Scholar]
  15. Rothstein J. D. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol. 1995;68:7–27. [PubMed] [Google Scholar]
  16. Sher E., Gotti C., Canal N., Scoppetta C., Piccolo G., Evoli A., Clementi F. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet. 1989 Sep 16;2(8664):640–643. doi: 10.1016/s0140-6736(89)90893-3. [DOI] [PubMed] [Google Scholar]
  17. Smith R. G., Alexianu M. E., Crawford G., Nyormoi O., Stefani E., Appel S. H. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3393–3397. doi: 10.1073/pnas.91.8.3393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Smith R. G., Hamilton S., Hofmann F., Schneider T., Nastainczyk W., Birnbaumer L., Stefani E., Appel S. H. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med. 1992 Dec 10;327(24):1721–1728. doi: 10.1056/NEJM199212103272405. [DOI] [PubMed] [Google Scholar]
  19. Thompson S. M., Capogna M., Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci. 1993 Jun;16(6):222–227. doi: 10.1016/0166-2236(93)90160-n. [DOI] [PubMed] [Google Scholar]
  20. Tong G., Shepherd D., Jahr C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 1995 Mar 10;267(5203):1510–1512. doi: 10.1126/science.7878472. [DOI] [PubMed] [Google Scholar]
  21. Twyman R. E., Gahring L. C., Spiess J., Rogers S. W. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron. 1995 Apr;14(4):755–762. doi: 10.1016/0896-6273(95)90219-8. [DOI] [PubMed] [Google Scholar]
  22. Uchitel O. D., Appel S. H., Crawford F., Sczcupak L. Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7371–7374. doi: 10.1073/pnas.85.19.7371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Uchitel O. D., Scornik F., Protti D. A., Fumberg C. G., Alvarez V., Appel S. H. Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology. 1992 Nov;42(11):2175–2180. doi: 10.1212/wnl.42.11.2175. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES